Stock Alert: Accelerate Diagnostics (AXDX) Up 7.14% in Pre-Market Hours for June 23

Equities Staff  |

Shares of Accelerate Diagnostics Inc (NASDAQ:AXDX) are on the move in pre-market trading for June 23.

Ahead of the market's open, Accelerate Diagnostics stock has risen 7.14% from the previous session’s close.

Accelerate Diagnostics was up $0.246 in the last session and looks to continue today.

For technical charts, analysis, and more on Accelerate Diagnostics visit the company profile.

Pre-market prices and movements as of 08:03:18 est.

About Accelerate Diagnostics Inc

Accelerate Diagnostics, Inc. is an in vitro diagnostics company dedicated to providing solutions for the global challenges of antibiotic resistance and sepsis. The Accelerate Pheno® system and Accelerate PhenoTest® BC kit combine several technologies aimed at reducing the time clinicians must wait to determine the most optimal antibiotic therapy for deadly infections. The FDA cleared system and kit fully automate the sample preparation steps to report phenotypic antibiotic susceptibility results in approximately 7 hours direct from positive blood cultures. Recent external studies indicate the solution offers results 1-2 days faster than existing methods, enabling clinicians to optimize antibiotic selection and dosage specific to the individual patient days earlier.

To get more information on Accelerate Diagnostics Inc and to follow the company's latest updates, you can visit the company's profile page here: Accelerate Diagnostics Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content